ID   NOM1
AC   CVCL_RN35
SY   Nagoya Ovarian Mucinous 1
DR   Wikidata; Q54930894
RX   PubMed=8978593;
RX   PubMed=9344045;
RX   PubMed=9891486;
CC   Population: Japanese.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
RX   PubMed=9344045; DOI=10.1023/A:1018495414975;
RA   Shibata, Kiyosumi
RA   Kikkawa, Fumitaka
RA   Nawa, Akihiro
RA   Tamakoshi, Koji
RA   Suganuma, Nobuhiko
RA   Tomoda, Yutaka
RT   "Increased matrix metalloproteinase-9 activity in human ovarian cancer
RT   cells cultured with conditioned medium from human peritoneal tissue.";
RL   Clin. Exp. Metastasis 15:612-619(1997).
//
RX   PubMed=8978593; DOI=10.1159/000227661;
RA   Wakahara, Yasunori
RA   Nawa, Akihiro
RA   Okamoto, Tomomitsu
RA   Hayakawa, Akemi
RA   Kikkawa, Fumitaka
RA   Suganama, Nobuhiko
RA   Wakahara, Fumiyo
RA   Tomoda, Yutaka
RT   "Combination effect of anti-Fas antibody and chemotherapeutic drugs in
RT   ovarian cancer cells in vitro.";
RL   Oncology 54:48-54(1997).
//
RX   PubMed=9891486;
RA   Kikkawa, Fumitaka
RA   Nawa, Akihiro
RA   Shibata, Kiyosumi
RA   Obata, Naoko H.
RA   Tamakoshi, Koji
RA   Suzuki, Shoji
RA   Mizutani, Shigehiko
RT   "The different stimulatory effect of normal tissues on the secretion
RT   of matrix metalloproteinases and their inhibitors by human ovarian
RT   cancer cells.";
RL   Anticancer Res. 18:4323-4328(1998).
//